Edition:
United Kingdom

Almirall SA (ALM.MC)

ALM.MC on Madrid SE C.A.T.S.

8.74EUR
8:59am GMT
Change (% chg)

€-0.12 (-1.35%)
Prev Close
€8.86
Open
€8.82
Day's High
€8.88
Day's Low
€8.69
Volume
70,037
Avg. Vol
460,643
52-wk High
€16.88
52-wk Low
€7.28

Summary

Name Age Since Current Position

Jorge Gallardo Ballart

2011 Chairman of the Board

Peter Guenter

55 2017 Chief Executive Officer

Daniel Bravo Andreu

2006 Second Vice Chairman of the Board

David Nieto

2017 Chief Financial Officer, Executive Vice President - Finance

Bhushan Hardas

2017 Chief Scientific Officer y Executive Vice President Research and Development

Thomas Eichholtz

2016 Executive Vice President - Research & Development, CSO

Alfredo Baron de Juan

2016 Executive Vice President - Global Commercial Operations

Alfonso Ugarte Castillo

2016 Executive Vice President - Global Commercial Strategy

Jordi Sabe Richer

2016 Senior Vice President - Corporate Development

Javier Arroniz Morera de la Vall

2016 Senior Vice President of Human Resources

Amita Kent

2016 Vice President - Legal Affairs

Eloi Crespo Cervera

2016 Vice President - Manufacturing & Technical Services

Joan Figueras Carreras

Corporate General Counsel

Jorge Salvat Filomeno

Director of Internal Audit

Jose Juan Pinto Sala

2016 Non-Member Secretary of the Board

Carlos Gallardo Pique

2014 Director

Antonio Gallardo Torrededia

2014 Director

Juan Arena de la Mora

74 2007 Independent Director

Karin Dorrepaal

56 2013 Independent Director

Georgia Garinois-Melenikiotou

2016 Independent Director

Gerhard Mayr

70 2012 Independent Director

Thomas McKillop

74 2007 Independent Director

Seth Orlow

2016 Independent Director

Biographies

Name Description

Jorge Gallardo Ballart

Mr. Jorge Gallardo Ballart serves as Chairman of the Board of Directors of Almirall, S.A. Previously, he acted as Chief Executive Officer of the Company until March 17, 2011, and was Executive Member of the Company's Board until July 1, 2011. He joined the Company on November 1, 1965, and has been on the Company's Board since June 30, 1997. He is also Member of the Company's Nominating and Remuneration Committee. He has served as Administrator of Almirall, BV, Almirall AG, Chemol SA, Expharm SA and Almirall SA in Chile, as well as President of GdS SAS. Currently, he acts as Chairman of the Board of Directors of Grupo Plafin SA UNIP. He holds a degree in Industrial Engineering from Universidad Politecnica de Madrid.

Peter Guenter

Mr. Peter Guenter has been appointed as Chief Executive Officer of Almirall, S.A. since October 1, 2017. Prior to that, he was Executive Vice President, General Medicines and Emerging Markets, Member of the Executive Committee and the Global Leadership Team from mid-2015 and Executive Vice President in charge of Global Commercial Operations and Member of the Executive Committee and the Global Leadership Team of the Company from July 1, 2013. He holds a Masters Degree in Physical Education at the Faculty of Medicine and Health Sciences, University of Ghent, Belgium. He started his career in Sales at SmithKline in 1986. He joined the Group in 1995 and held various positions in France, Europe and Global Marketing. In 2000, he was appointed General Manager Belgium and then Vice President for Eastern Europe, Northern Europe & Scandinavia. In 2008, he was appointed General Manager, Commercial Operations for Germany, and in 2011, he was General Manager for the Multi-Country- Organization for Germany, Switzerland and Austria.

Daniel Bravo Andreu

Mr. Daniel Bravo Andreu serves as Second Vice Chairman of the Board of Directors of Almirall, S.A.. He has been on the Company's Board since June 30, 1997, and appointed to his current post on October 18, 2006. In addition, he is Member and Secretary of the Company's Audit Committee.

David Nieto

Mr. David Nieto serves as Chief Financial Officer, Executive Vice President - Finance of Almirall, S.A. since February 1, 2017. Previously, he was Division CFO for Novartis Vaccines & Diagnostics, where he led the Finance, IT and Procurement organizations since January 1, 2012. Prior to Novartis, Mr. Nieto spent 15 years with Nestle where he held a range of fi nance positions with increasing responsibilities in the nutrition and Nespresso businesses. More recently, he was Senior Vice President & Chief Financial Officer of Nestle Nutrition North America since 2007, based in New Jersey, where he led the acquisitions and integrations of Gerber, Novartis Medical Nutrition and Jenny Craig into Nestle. Mr. Nieto holds a Master’s and Bachelor’s degree in Business Administration, both from the University of Lausanne in Switzerland.

Bhushan Hardas

Dr. Bhushan Hardas serves as Chief Scientific Officer y Executive Vice President Research and Development of Almirall, S.A. since April 1, 2017. His last position before joining Almirall, he has been the Global Head of R & D Dermatology and Medical Aesthetics and Chief Medical Officer (Devices) in Allergan, located in Irvine, California. He holds a Masters of Business Administration degree.

Thomas Eichholtz

Alfredo Baron de Juan

Alfonso Ugarte Castillo

Jordi Sabe Richer

Javier Arroniz Morera de la Vall

Amita Kent

Eloi Crespo Cervera

Mr. Eloi Crespo Cervera serves as Vice President - Manufacturing & Technical Services at Almirall, SA. Prior to this he was Senior Director of Industrial Area at the Company.

Joan Figueras Carreras

Mr. Joan Figueras Carreras serves as Corporate General Counsel of Almirall, S.A.. He joined the Company on October 1, 1991.

Jorge Salvat Filomeno

Jose Juan Pinto Sala

Carlos Gallardo Pique

Mr. Carlos Gallardo Pique serves as Director of Almirall, S.A. since August 28, 2014. He has held positions in several companies in the pharmaceutical sector. He holds a degree in Industrial Engineering and MBA.

Antonio Gallardo Torrededia

Mr. Antonio Gallardo Torrededia serves as Director of Almirall, S.A. He has held positions in several companies in the pharmaceutical sector. He holds a degree in Business Administration and Management.

Juan Arena de la Mora

Mr. Juan Arena de la Mora serves as Independent Director of Almirall, S.A. since May 29, 2007. He is Chairman of the Company's Audit Committee. Currently, he acts as Board Member of Prisa, Grupo Ferrovial SA, Dinamia Capital Privado SCR SA and Sol Melia SA. He holds a Master of Business Administration degree from Universidad Pontificia Comillas, as well as a Doctorate in Philosophy degree in Electromechanical Engineering and a Bachelors degree in Business Administration from the same University. In addition, he holds a degree in Management from the Harvard Business School.

Karin Dorrepaal

Ms. Karin Louise Dorrepaal serves as Independent Director of Almirall, S.A. She is Member of Company's Audit Committee. She has held this post since January 1, 2013. She holds a PhD degree in Medicine and MBA.

Georgia Garinois-Melenikiotou

Gerhard Mayr

Mr. Gerhard N. Mayr serves as Independent Director of Almirall, S.A. since October 19, 2012. He acts as a Member of Company's Nominating and Remuneration Commitee. He was Member of the Audit Commitee of the Company. He is also Member of the Board of Directors of UCB SA. He holds a Masters of Business Administration degree from the Stanford University (1972) and a Master's degree in Chemical Engineering from Eidgenoessische Technische Hochschule Zuerich (1969).

Thomas McKillop

Mr. Thomas F. (Tom) McKillop serves as Independent Director of Almirall, S.A. since May 29, 2007. He is Chairman of the Company's Nominating and Remuneration Committee. He has also served as Board Member of Lloyds Banking Group PLC, Amersham PLC, BP PLC, Evolva Holding SA and UCB SA; CEO and Board Member of AstraZeneca PLC, and Chairman of the Board of Directors of Royal Bank of Scotland Group PLC. He holds a Doctorate in Philosophy degree in Chemistry and a Bachelor of Science degree in Chemistry, both from the University of Glasgow.

Seth Orlow